Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | CTSL | P07711 | 1/20 | 0.44 |
| ▸ | CTSB | P07858 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA7 | P43166 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | BCHE | P06276 | 1/20 | 0.42 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | GBA1 | P04062 | 2/20 | 0.42 |
| ▸ | UGCG | Q16739 | 2/20 | 0.42 |
| ▸ | GBA2 | Q9HCG7 | 2/20 | 0.42 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18516986 | 1.00 | TSHR (0.50) | TSHRCTSLCTSBCTSKCA1 | |
| SCHEMBL18516989 | 0.87 | BCHE (0.49) | TSHRCTSLCTSBCTSKTAAR1 | |
| SCHEMBL24007625 | 0.84 | TSHR (0.48) | TSHRCTSLCTSBCTSKTAAR1 | |
| SCHEMBL26024052 | 0.84 | TSHR (0.48) | TSHRCTSLCTSBCTSKTAAR1 | |
| SCHEMBL24815520 | 0.84 | TSHR (0.48) | TSHRCTSLCTSBCTSKTAAR1 | |
| SCHEMBL25746130 | 0.84 | TSHR (0.48) | TSHRCTSLCTSBCTSKTAAR1 | |
| SCHEMBL21783268 | 0.83 | BCHE (0.52) | TSHRCTSLCTSBCTSKBCHE | |
| SCHEMBL9418302 | 0.82 | TSHR (0.47) | TSHRCTSLCTSBCTSKCA1 | |
| SCHEMBL10803209 | 0.81 | PTPN1 (0.40) | TSHRLMNAGBA1UGCGGBA2 | |
| SCHEMBL19914976 | 0.81 | ALDH1A1 (0.40) | TSHRCTSLCTSBCTSKLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2433941-A1 | Process for isolating the antiviral agent [1S-(1alpha, 3alpha, 4beta)]-2-amino-1,9-dihydro-9-[4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-6H-purin-6-one | Bristol-Myers Squibb Company (US) | 2012-03-28 | — | — | EP | disclosed |